Goodman Advisory Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1864123
NEEDHAM, MA
Position in VRTX
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$138,873
-$32,950 QoQ
Shares Held
311
-17.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
15 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Goodman Advisory Group, LLC holds $15,269,430 across 1 Biotechnology name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
272,328 | $15,269,430 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $138,873 | 311 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $171,823 | 379 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $148,431 | 379 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $178,080 | 400 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $215,260 | 444 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $228,819 | 492 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $230,610 | 492 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $208,586 | 499 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $200,189 | 492 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $171,088 | 492 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $183,345 | 521 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $164,151 | 521 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $229,580 | 795 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $150,850 | 521 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $146,812 | 521 | Shares | Sole | 2022-08-03 | |
| No filing history on record for this holder in this stock. | ||||||